(Q34179048)

31 July 2017

1 reference

title

Antitumor activity of Corynebacterium parvum (English)

1 reference

31 July 2017

Luka Milas

1

0 references

Martin T. Scott

2

0 references

L. Milas

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A343523

1 April 2023

M. T. Scott

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A343523

1 April 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=343523

1 April 2023

publication date

1 January 1978

1 reference

Advances in Cancer Research

31 July 2017

1978

0 references

published in

1 reference

31 July 2017

26

1 reference

31 July 2017

257-306

1 reference

Studies on the histamine sensitisation produced in mice by Corynebacterium parvum

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Lympho-Reticular Stimulatory Properties of Corynebacterium Parvum and Related Bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Differences between the Electrical Charge carried by Normal and Homologous Tumour Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

An experimental model of active immunotherapy preceded by cytoreductive chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

REACTIONS OF NORMAL AND TUMOR CELL SURFACES TO ENZYMES. I. WHEAT-GERM LIPASE AND ASSOCIATED MUCOPOLYSACCHARIDES

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Chemical and immunological studies on the cell walls of Propionibacterium acnes strain C7 and Corynebacterium parvum ATCC 11829

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Destruction of Hamster Ovarian Cell Cultures by Peritoneal Macrophages From Mice Treated With Corynebacterium granulosum

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

In Vitro Destruction of Tumor Cells by Macrophages From Mice Treated With Corynebacterium granulosum2

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

BCG and cancer (first of two parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Letter: Methyl-cholanthrene-induced sarcomata in mice after immunisation with Corynebacterium parvum plus syngeneic subcellular membrane fractions.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Antitumour effect of corynebacterium parvum. Possible mode of action

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

MODIFICATIONS OF GRAFT-VERSUS-HOST REACTION INDUCED BY PRETREATMENT OF THE HOST WITH M. TUBERCULOSIS AND C. PARVUM

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Active specific immunotherapy of mouse methylcholanthrene induced tumours with Corynebacterium parvum and irradiated tumour cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Mechanisms of macrophage activation by corynebacterium parvum. II. In vivo experiments

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

The mechanism of inhibition by Corynebacterium parvum of the growth of lung nodules from intravenously injected tumour cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

A difference in the architecture of the surface membrane of normal and virally transformed cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

An endotoxin-induced serum factor that causes necrosis of tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

The effect of Corynebacterium parvum on the structure and function of the lymphoid system in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Antitumour effects of Corynebacterium parvum in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Nonspecific immunotherapy by Corynebacterium parvum: phase I toxicity study in 12 patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Mechanisms of macrophage activation by Corynebacterium parvum. I. In vitro experiments

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Tumor cytotoxicity in vitro by macrophages from mice infected with mycobacterium bovis strain BCG.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Peculiar immunobiology of bone marrow allografts. I. Graft rejection by irradiated responder mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Peculiar immunobiology of bone marrow allografts. II. Rejection of parental grafts by resistant F 1 hybrid mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Corynebacterium parvum: a Synonym for Propionibacterium acnes?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Active Immunotherapy with Corynebacterium parvum and Chemotherapy in Murine Fibrosarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Analysis of anaerobic coryneform cell wall antigens by radioimmunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Effects of fat-soluble compounds on lysosomes in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Quantitative effect of Mycobacteria and of anaerobic Corynebacteria upon immunogenic activity of azobenzearsonate-N-acetyl-L-tyrosine in guinea pigs.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Effect of adjuvants on the antibody response to a hapten on a thymus-independent carrier

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Effect of Corynebacterium Parvum on Bone Marrow Cell Cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Letter: Corynebacterium parvum and anaesthetics

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Immunostimulation with bacterial phospholipid extracts

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Further Observations on the Inhibition of Tumor Growth by Corynebacterium parvum With Cyclophosphamide. I. Variation in Administration of Both Agents2

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Inhibitory effect of prolongedcorynebacterium parvum and cyclophosphamide administration on the growth of established tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Further Observations on the Inhibition of Tumor Growth by Corynebacterium parvum With Cyclophosphamide. II. Effect of Cortisone Acetate 2

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Observations following Corynebacterium parvum administration to patients with advanced malignancy. a phase I study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

The effect of nonspecific immune stimulation with corynebacterium parvum on patterns of tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Anti-Tumour Effect In Vitro of Lymphocytes and Macrophages from Mice Treated with Corynebacterium Parvum

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Further analysis of the anti-tumour effect in vitro of peritoneal exudate cells from mice treated with Corynebacterium parvum

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Glycolipids of hamster fibroblasts and derived malignant-transformed cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Inhibition of Tumour Growth by Administration of Killed Corynebacterium parvum

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Antigen-induced stimulation of glucosamine incorporation by guinea pig peritoneal macrophages in delayed hypersensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Macrophage nonimmunologic recognition: target cell factors related to contact inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Heterocytolysis by macrophages activated by bacillus Calmette-Guérin: lysosome exocytosis into tumor cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Possible role of macrophage mediated nonspecific cytotoxicity in tumour resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Biological effects of Corynebacterium parvum. IV. Adjuvant and inhibitory activities on B lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Daily intravenous infusions of Corynebacterium parvum in twenty patients with disseminated cancer: a preliminary report of clinical and biologic findings

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

The effect of transplanted methylcholanthrene induced fibrosarcomata and Corynebacterium parvum on the immune response of CBA and A-HeJ mice to thymus dependent and independent antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

The effect of Corynebacterium parvum therapy on immunoglobulin class and IgG subclass levels in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Antitumor antibodies and immunoglobulin class and subclass levels in Corynebacterium parvum-treated mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Suppression of cell-mediated tumour immunity by Corynebacterium parvum

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Rejection of tumors and metastases in Fischer 344 rats following intratumor administration of killed Corynebacterium parvum.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Suppression of the incidence of death with spontaneous tumours in DBA/2 mice after Corynebacterium parvum-mediated rejection of syngeneic tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

The delayed rejection of tumors formed from the administration of tumor cells mixed with killed Corynebacterium parvum.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

The effect of gold salts on tumour immunity and its stimulation by Corynebacterium Parvum

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Effect of Corynebacterium parvum on cellular and humoral antitumoral immune effector mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Active immunotherapy of L1210 leukaemia applied after the graft of tumour cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Study of the mechanism of Corynebacterium parvum anti-tumour activity. I. Protective effect on the growth of two syngeneic tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Hydrosoluble immunopotentiating substances extraced from Corynebacterium parvum

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Letter: Anaerobic corynebacteria and anaesthetics

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Nonspecific Immunotherapy of Malignant Tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Immunoprophylaxis and immunotherapy for a murine fibrosarcoma with C. granulosum and C. parvum

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Protection by corynebacterium granulosum against radiation-induced enhancement of artificial pulmonary metastases of a murine fibrosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Combination ofC. parvum and specific immunization against artificial pulmonary metastases in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Nonspecific entry of thoracic duct immunoblasts into intradermal foci of antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Macrophage activation and anti-tumor activity of biologic and synthetic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Paradoxical effects of immunopotentiators on tumors and tumor viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Alterations of macrophage functions by mediators from lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Increased nonspecific resstance to malaria produced by administration of killed Corynebacterium parvum

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

The reticuloendothelial system and the neoplastic process

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

In vitro inhibition of tumour cell growth and DNA synthesis by peritoneal and lung macrophages from mice injected with Corynebacterium parvum

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Letter: Toxicity of intravenous Corynebacterium parvum

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Regression of a transplantable hamster melanoma by intralesional injections of Corynebacterium granulosum

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Combined Drug and Immunostimulation Therapy Against a Syngeneic Murine Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Histological and combined chemoimmunostimulation therapy studies against a murine leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

A cytochemical study of the in vitro interaction between normal and activated mouse peritoneal macrophages and tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

1 reference

7 January 2021

Intercellular contact and cell-surface galactosyl transferase activity (cell culture-mouse-radioautography-contact inhibition-cis-and trans-galactosylation).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Possible Immunosuppressive Effect of Corynebacterium parvum on Infection with Trichinella spiralis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Lack of immunological and anti-tumour effects of orally administered Corynebacterium parvum in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

The effects of Corynebacterium parvum and surgery on the Lewis lung carcinoma and its metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Ability of activated complement components to induce lysosomal enzyme release from macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Biological effects of the adjuvant Corynebacterium parvum. I. Inhibition of PHA, mixed lymphocyte and GVH reactivity.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Biological effects of the adjuvant Corynebacterium parvum. II. Evidence for macrophage-T-cell interaction.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Depression of delayed-type hypersensitivity by Corynebacterium parvum: mandatory role of the spleen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Corynebacterium parvum as a therapeutic antitumor agent in mice. I. Systemic effects from intravenous injection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Corynebacterium parvum as a therapeutic antitumor agent in mice. II. Local injection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

In vivo cortisone sensitivity of nonspecific antitumor activity of Corynebacterium parvum-activated mouse peritoneal macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Potentiation of the tumor-specific immune response by Corynebacterium parvum

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Failure of Corynebacterium parvum presensitization to modify the antitumor effects of systemic and local therapeutic injections of C. parvum in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Biological effects of Corynebacterium parvum. 3. Amplification of resistance and impairment of active immunity to murine tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Lymphopenia and change in distribution of human B and T lymphocytes in peripheral blood induced by irradiation for mammary carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Radiation response of C3H fibrosarcoma enhanced in mice stimulated by Corynebacterium parvum

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Radiation therapy and Corynebacterium parvum in the treatment of murine tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Modifications in the number of units of splenic colony-forming cells during bacterially induced non-specific immunostimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Mechanisms of Antitumor Action of Corynebacterium parvum : Nonspecific Tumor Cell Destruction at Site of an Immunologically Mediated Sensitivity Reaction to C. parvum 2

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Enhancement by drugs of metastatic lung nodule formation after intravenous tumour cell injection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Release of lysosomal protease by ultraviolet irradiation and inhibition by hydrocortisone

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

The role of macrophages in the amplified in vitro response to sheep red blood cells by spleen cells from Corynebacterium parvum treated mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Inhibitory effect of injection of Corynebacterium parvum on the growth of tumour transplants in isogenic hosts

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Effect of local injection of Corynebacterium parvum on the growth of a murine fibrosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Synergistic inhibition of mammary carcinoma transplants in A-strain mice by antitumour globulin and C. parvum

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Further observations on the effect of C. parvum and anti-tumour globulin on syngeneically transplanted mouse tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

The growth of tumours in T-cell deprived mice and their response to treatment with Corynebacterium parvum

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Protection of mice againstBabesiaspp. andplasmodiumspp. with killedCorynebacterium parvum

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Skin grafting across the H-Y barrier and the effect of biological adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Effect of Corynebacterium parvum Treatment on the Growth of Salmonella enteritidis in Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Effect of Corynebacterium acnes on Interferon Production in Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Cell Wall Composition and Deoxyribonucleic Acid Similarities Among the Anaerobic Coryneforms, Classical Propionibacteria, and Strains ofArachnia propionica

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Enhancement of resistance and suppression of immunization against experimental Trypanosoma cruzi infection by Corynebacterium parvum

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Hybrid resistance to parental WB-Re bone marrow grafts. Association with genetic markers of linkage group IX.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Effect of immunisation with heat-killed micro-organisms on transplantation immunity to adenovirus-12-induced tumour cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Dichotomy between macrophage activation and degree of protection against Listeria monocytogenes and Toxoplasma gondii in mice stimulated with Corynebacterium parvum

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960090-1

7 January 2021

Adjuvant activity of mycobacterial fractions: adjuvant activity of synthetic N-acetylmuramyl-dipeptide and the related compounds

13

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60090-1

Effect of Corynebacterium acnes on interferon production in mouse peritoneal exudate cells

1 April 2023

62

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60090-1

1 April 2023

115

34

341

Likhite

1974

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60090-1

1 April 2023

126

33

1987

Mathé

1973

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60090-1

1 April 2023

134

34

613

Milas

1974

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60090-1

1 April 2023

135

34

2470

Milas

1974

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60090-1

1 April 2023

136

35

1274

Milas

1975

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60090-1

1 April 2023

138

35

2365

Milas

1975

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60090-1

1 April 2023

154

21

1281

Old

1961

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60090-1

1 April 2023

159

32

904

Pearson

1972

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60090-1

1 April 2023

160

34

355

Pearson

1974

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60090-1

1 April 2023

Corynebacterium parvum

183

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60090-1

1 April 2023

200

36

1335

Scott

1976

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60090-1

1 April 2023

209

36

1305

Suit

1976

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60090-1

1 April 2023

232

34

2869

Wolmark

1974

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60090-1

1 April 2023

243

36

161

Yuhas

1976

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60090-1

1 April 2023

244

35

242

Yuhas

1975

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60090-1

1 April 2023

Identifiers

0 references

1 reference